Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice

Ching Hao Li, Chuan Chou Shen, Yu Wen Cheng, Shih Hsuan Huang, Chung Che Wu, Chen Chieh Kao, Jiunn Wang Liao, Jaw Jou Kang

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Understanding tissue biodistribution and clearance of zinc oxide nanoparticles (ZnO-NPs) is necessary for its risk assessment. Both fed and intraperitoneally injected ZnO-NPs (2.5 g/kg) were absorbed into circulation (within 30 min post-dosing), then biodistributed to the liver, spleen, and kidney. Intraperitoneally injected ZnO-NPs remained in serum for 72 h and could more effectively spread to the heart, lung, and testes, whereas the clearance for fed ZnO-NPs in serum began 6 h after oral administration. Compared with zinc oxide microparticles (ZnO-MPs), ZnO-NPs exhibited much higher absorptivity and tissue biodistribution in fed treatment. A greater fraction of fed ZnO-NPs localised in the liver resulted in transient histopathological lesions. However, superoxide generation and cytotoxicity were showed in vitro treatment with ZnO-NPs (above 20 μg/mL). Considering both in vitro and in vivo data, the ZnO-NPs induced acute liver toxicity which was in compliance with its absorption, biodistribution, and clearance.

Original languageEnglish
Pages (from-to)746-756
Number of pages11
JournalNanotoxicology
Volume6
Issue number7
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Zinc Oxide
Zinc oxide
Nanoparticles
Liver
Tissue
Cytotoxicity
Serum
Superoxides
Risk assessment
Oral Administration
Toxicity
Testis
Spleen
Kidney
Lung

Keywords

  • Absorption
  • Biodistribution
  • Clearance
  • Nanoparticles
  • Zinc oxide

ASJC Scopus subject areas

  • Biomedical Engineering
  • Toxicology

Cite this

Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. / Li, Ching Hao; Shen, Chuan Chou; Cheng, Yu Wen; Huang, Shih Hsuan; Wu, Chung Che; Kao, Chen Chieh; Liao, Jiunn Wang; Kang, Jaw Jou.

In: Nanotoxicology, Vol. 6, No. 7, 11.2012, p. 746-756.

Research output: Contribution to journalArticle

Li, Ching Hao ; Shen, Chuan Chou ; Cheng, Yu Wen ; Huang, Shih Hsuan ; Wu, Chung Che ; Kao, Chen Chieh ; Liao, Jiunn Wang ; Kang, Jaw Jou. / Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. In: Nanotoxicology. 2012 ; Vol. 6, No. 7. pp. 746-756.
@article{52b59d18541841a189c1cd47a91a4114,
title = "Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice",
abstract = "Understanding tissue biodistribution and clearance of zinc oxide nanoparticles (ZnO-NPs) is necessary for its risk assessment. Both fed and intraperitoneally injected ZnO-NPs (2.5 g/kg) were absorbed into circulation (within 30 min post-dosing), then biodistributed to the liver, spleen, and kidney. Intraperitoneally injected ZnO-NPs remained in serum for 72 h and could more effectively spread to the heart, lung, and testes, whereas the clearance for fed ZnO-NPs in serum began 6 h after oral administration. Compared with zinc oxide microparticles (ZnO-MPs), ZnO-NPs exhibited much higher absorptivity and tissue biodistribution in fed treatment. A greater fraction of fed ZnO-NPs localised in the liver resulted in transient histopathological lesions. However, superoxide generation and cytotoxicity were showed in vitro treatment with ZnO-NPs (above 20 μg/mL). Considering both in vitro and in vivo data, the ZnO-NPs induced acute liver toxicity which was in compliance with its absorption, biodistribution, and clearance.",
keywords = "Absorption, Biodistribution, Clearance, Nanoparticles, Zinc oxide",
author = "Li, {Ching Hao} and Shen, {Chuan Chou} and Cheng, {Yu Wen} and Huang, {Shih Hsuan} and Wu, {Chung Che} and Kao, {Chen Chieh} and Liao, {Jiunn Wang} and Kang, {Jaw Jou}",
year = "2012",
month = "11",
doi = "10.3109/17435390.2011.620717",
language = "English",
volume = "6",
pages = "746--756",
journal = "Nanotoxicology",
issn = "1743-5390",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice

AU - Li, Ching Hao

AU - Shen, Chuan Chou

AU - Cheng, Yu Wen

AU - Huang, Shih Hsuan

AU - Wu, Chung Che

AU - Kao, Chen Chieh

AU - Liao, Jiunn Wang

AU - Kang, Jaw Jou

PY - 2012/11

Y1 - 2012/11

N2 - Understanding tissue biodistribution and clearance of zinc oxide nanoparticles (ZnO-NPs) is necessary for its risk assessment. Both fed and intraperitoneally injected ZnO-NPs (2.5 g/kg) were absorbed into circulation (within 30 min post-dosing), then biodistributed to the liver, spleen, and kidney. Intraperitoneally injected ZnO-NPs remained in serum for 72 h and could more effectively spread to the heart, lung, and testes, whereas the clearance for fed ZnO-NPs in serum began 6 h after oral administration. Compared with zinc oxide microparticles (ZnO-MPs), ZnO-NPs exhibited much higher absorptivity and tissue biodistribution in fed treatment. A greater fraction of fed ZnO-NPs localised in the liver resulted in transient histopathological lesions. However, superoxide generation and cytotoxicity were showed in vitro treatment with ZnO-NPs (above 20 μg/mL). Considering both in vitro and in vivo data, the ZnO-NPs induced acute liver toxicity which was in compliance with its absorption, biodistribution, and clearance.

AB - Understanding tissue biodistribution and clearance of zinc oxide nanoparticles (ZnO-NPs) is necessary for its risk assessment. Both fed and intraperitoneally injected ZnO-NPs (2.5 g/kg) were absorbed into circulation (within 30 min post-dosing), then biodistributed to the liver, spleen, and kidney. Intraperitoneally injected ZnO-NPs remained in serum for 72 h and could more effectively spread to the heart, lung, and testes, whereas the clearance for fed ZnO-NPs in serum began 6 h after oral administration. Compared with zinc oxide microparticles (ZnO-MPs), ZnO-NPs exhibited much higher absorptivity and tissue biodistribution in fed treatment. A greater fraction of fed ZnO-NPs localised in the liver resulted in transient histopathological lesions. However, superoxide generation and cytotoxicity were showed in vitro treatment with ZnO-NPs (above 20 μg/mL). Considering both in vitro and in vivo data, the ZnO-NPs induced acute liver toxicity which was in compliance with its absorption, biodistribution, and clearance.

KW - Absorption

KW - Biodistribution

KW - Clearance

KW - Nanoparticles

KW - Zinc oxide

UR - http://www.scopus.com/inward/record.url?scp=84867487945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867487945&partnerID=8YFLogxK

U2 - 10.3109/17435390.2011.620717

DO - 10.3109/17435390.2011.620717

M3 - Article

C2 - 21950449

AN - SCOPUS:84867487945

VL - 6

SP - 746

EP - 756

JO - Nanotoxicology

JF - Nanotoxicology

SN - 1743-5390

IS - 7

ER -